CVS
CVS Health Corp
NYSE: CVS · HEALTHCARE · HEALTHCARE PLANS
$92.22
+1.17% today
Updated 2026-06-05
Market cap
$128.46B
P/E ratio
44.16
P/S ratio
0.32x
EPS (TTM)
$2.28
Dividend yield
2.61%
52W range
$57 – $103
Volume
8.0M
WallStSmart proprietary scores
65
out of 100
Grade: B
Buy
Investment rating
7.3
Growth
B+5.0
Quality
C+4.0
Profitability
C8.0
Valuation
A4/9
Piotroski F-Score
Moderate
2.1
Altman Z-Score
Grey zone
—
Industry rank
—
View all highly rated stocks (75+) →199 stocks currently score above 75
Price targets
Analyst target
$94.61
+2.59%
12-Month target
$42.02
-54.44%
Intrinsic (DCF)
$141.01
Margin of safety
+45.38%
6 Strong Buy18 Buy4 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $3.40B — positive
+ 45.38% below intrinsic value
Risks
- Thin margins at 0.72%
- P/E 44.16x — expensive valuation
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $322.47B | $357.78B | $372.81B | $402.07B | $405.62B | $409.6B |
| Net income | $4.31B | $8.34B | $4.61B | $1.77B | $2.94B | — |
| EPS | — | — | — | — | $2.28 | $7.25 |
| Free cash flow | $13.45B | $10.39B | $6.33B | $7.81B | $3.40B | — |
| Profit margin | 1.34% | 2.33% | 1.24% | 0.44% | 0.72% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-05-31 | NEWMAN, BRIAN | Sale | 2,478 | $90.98 |
| 2026-05-31 | COMPTON-PHILLIPS, AMY | Sale | 7,618 | $90.98 |
| 2026-05-21 | ROBBINS, LARRY | Sale | 370,462 | $93.45 |
Peer comparison
Smart narrative
CVS Health Corp trades at $92.22. representing a P/E of 44.16x trailing earnings. Our Smart Value Score of 65/100 indicates the stock is good. The company scores 4/9 on the Piotroski F-Score. With an Altman Z-Score of 2.11, it sits in the grey zone. TTM revenue stands at $405.62B. with profit margins at 0.72%. Our DCF model estimates intrinsic value at $141.01.
Frequently asked questions
What is CVS Health Corp's stock price?
CVS Health Corp (CVS) trades at $92.22, on a P/E of 44.2x and a P/S of 0.3x. Those multiples show what the market is paying for each dollar of earnings and sales, which is the real starting point for judging whether the price is reasonable.
Is CVS Health Corp overvalued?
CVS Health Corp carries a Smart Value Score of 65/100 (Grade B), which we rate Buy. That score blends growth, quality, and valuation into one read. Our DCF puts intrinsic value at $141.01 versus the $92.22 price, a 45.4% margin of safety on a cash flow basis.
What is the price target of CVS Health Corp (CVS)?
The 12-month analyst consensus target is $94.61, about 2.6% above the current $92.22. A consensus target is the average of Wall Street's 12-month forecasts, so it works as a sentiment gauge rather than a guarantee, and it resets with every earnings cycle.
What is the future stock price of CVS by 2030?
Our research-backed model puts the 2030 base case at $4,681.31, built from revenue projections, a growth-adjusted P/S multiple, net debt, and share dilution. It is a scenario rather than a prediction, and the bull and bear cases around it matter more than the single number when you are sizing a position.
What is the intrinsic value of CVS Health Corp (CVS)?
Our DCF model estimates intrinsic value at $141.01, a +45.4% margin of safety versus today's $92.22. Intrinsic value is what the projected cash flows are worth today. A positive reading means the price sits below that estimate, leaving a cushion if growth holds.
What is CVS Health Corp's revenue?
CVS Health Corp's trailing twelve-month revenue is $405.62B, and our model projects it reaching about $489.80B by 2030. Revenue scale anchors the valuation multiples and shows whether growth is reaching the top line, so it is best read alongside margin and growth trends to see if that revenue is getting more profitable over time.
Altman Z-Score?
CVS Health Corp's Altman Z-Score is 2.11, which places it in the grey zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.
Company info
SectorHEALTHCARE
IndustryHEALTHCARE PLANS
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.32x
ROE3.79%
Beta0.62
50D MA$87.39
200D MA$79.83
Shares out1.28B
Float1.27B
Short ratio—
Avg volume8.0M
Performance
1 week+0.00%
1 month+2.80%
3 months+35.34%
YTD+20.88%
1 year—
3 years—
5 years—